Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
The incidence of AEs was markedly lower with canagliflozin (RR = 0.77, 95% CrI: 0.66, 0.90), dapagliflozin (RR = 0.80, 95% CrI: 0.69, 0.94), empagliflozin (RR = 0.79, 95% CrI: 0.67, 0.92), ertugliflozin (RR = 0.78, 95% CrI: 0.66, 0.94), linagliptin (RR = 0.79, 95% CrI: 0.67, 0.92), omarigliptin (RR = 0.75, 95% CrI: 0.59, 0.96), placebo (RR = 0.8, 95% CrI: 0.68, 0.93), sotagliflozin (RR = 0.81, 95% CrI: 0.67, 0.99), and vildagliptin (RR = 0.76, 95% CrI: 0.63, 0.92) than dapagliflozin + saxagliptin
Common examples include hypertension, dyslipidaemia, and obstructive sleep apnea (Novo Nordisk Pharmaceuticals Ltd)
Parveen, N
Bose M, Machineni S, Olivn B, Teixeira J, McGinty JJ, Bawa B, et al
Saxenda , el nombre comercial de la liraglutida y como se le encuentra en Per , se comercializa tambin para el tratamiento de pacientes que padecen de diabetes tipo 2 con sobrepeso
LifeMD's consultation model does not include genetic testing
